← Open Payments lookup

MAVRA KEAR: Open Payments

NPI 1558357418 · LAKELAND, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,574 in 84 payments from 14 companies in 2025. Trend: 2023 $1,507 · 2024 $1,650 · 2025 $1,574

Food & beverage: $1,574
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.12$317
Otsuka America Pharmaceutical, Inc.22$252
Neurocrine BioSciences, Inc.8$238
Axsome Therapeutics, Inc.9$200
Teva Pharmaceuticals USA, Inc.15$170
Alkermes, Inc.4$78
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$71
Janssen Pharmaceuticals, Inc3$58
Lundbeck LLC2$52
Vanda Pharmaceuticals Inc.2$41

Products named: COBENFY, INGREZZA, Auvelity, ABILIFY MAINTENA, REXULTI, UZEDY, AUSTEDO XR, ARISTADA.

Industry payments across FL — which companies pay providers there.